Deubiquitinases in the regulation of NF-kappa B signaling

Nuclear factor-kappa B (NF-kappa B) is a critical regulator of multiple biological functions including innate and adaptive immunity and cell survival. Activation of NF-kappa B is tightly regulated to preclude chronic signaling that may lead to persistent inflammation and cancer. Ubiquitination of key signaling molecules by E3 ubiquitin ligases has emerged as an important regulatory mechanism for NF-kappa B signaling. Deubiquitinases (DUBs) counteract E3 ligases and therefore play a prominent role in the downregulation of NF-kappa B signaling and homeostasis. Understanding the mechanisms of NF-kappa B downregulation by specific DUBs such as A20 and CYLD may provide therapeutic opportunities for the treatment of chronic inflammatory diseases and cancer.